Soheila Korourian

High Impact

Professor

UAMS

Last publication 2024 Last refreshed 2026-05-02

faculty

Pathology, College of Medicine

44 h-index 169 pubs 5,449 cited

Research Areas

Links

Google Scholar Research Group UAMS TRI Profile

OverviewAI-generated summary

Soheila Korourian, Professor in the Department of Pathology at the University of Arkansas for Medical Sciences, leads a research group focused on understanding the impact of diet on metabolic health and disease. Her work has investigated the effects of soy protein concentrate, with varying levels of isoflavones, on non-alcoholic fatty liver disease (NAFLD) in obese Zucker rats. Studies have examined how dietary soy protein can reverse obesity-induced liver steatosis and alter gut microbial composition, with findings suggesting these effects can occur independently of isoflavone levels.

Further research explores the relationship between obesity and liver steatosis, including the potential therapeutic effects of metformin treatment. Korourian's publications also touch upon the role of obesity in promoting oxidative stress and DNA damage in mammary tumors within rat models. Her scholarship metrics include an h-index of 44, with 169 total publications and 5,429 total citations. She is recognized as a high-impact researcher and has collaborated with researchers including Reza Hakkak, Elisabet Børsheim, Nathan C. Twaddle, and Michael Scott Robeson.

Metrics

h-index: 44
Publications: 169
Citations: 5,449

Selected Publications

Dietary soy protein reverses obesity-induced liver steatosis and alters fecal microbial composition independent of isoflavone level (2024)

3 citations DOI OpenAlex
Entrustable professional activities for cytopathology fellowship (2024)

1 citation DOI OpenAlex
Soy Protein Concentrate With Low and High Isoflavones Can Reverse Non-alcoholic Fatty Liver Disease Caused by Obesity and Alter Gut Microbial Composition (2024)

DOI OpenAlex
Long-Term Feeding Soy Protein Concentrates Protect Against Hepatic Steatosis Independent of Isoflavone Levels (2023)

4 citations DOI OpenAlex
Diet Containing Soy Protein Concentrate With Low and High Isoflavones for 9 Weeks Protects Against Non-alcoholic Fatty Liver Steatosis Using Obese Zucker Rats (2022)

15 citations DOI OpenAlex
Abstract 740: Obesity promotes liver pro-oxidative and DNA damage in mammary tumor of Zucker rats (2022)

DOI OpenAlex
Effects of 8 Weeks Feeding Diet with Low and High Isoflavones Soy Protein Concentrate on Serum Isoflavones in Non-alcoholic Fatty Liver Disease (NAFLD) Rat Model (2022)

DOI OpenAlex
Diet Containing Soy Protein Concentrate with Low and High Isoflavones for 18 Weeks Protects Against Non-alcoholic Fatty Liver Diseases (2022)

DOI OpenAlex
Effects of Obesity and Low and High Isoflavones in Soy Protein Concentrate Diet on Liver Steatosis (2021)

DOI OpenAlex
Effects of obesity and 10 weeks metformin treatment on liver steatosis (2021)

5 citations DOI OpenAlex